There has been a growing interest in the therapeutic potential of psychedelics, and several organizations are conducting or have conducted clinical trials using substances like psilocybin (found in "magic mushrooms") and MDMA for conditions like depression, PTSD, and end-of-life anxiety.
In recent years, ketamine, which is a legal prescription medication, has been used off-label for the treatment of conditions like depression and anxiety. This has led to the establishment of a number of ketamine clinics across the U.S. These clinics provide ketamine treatment, often in the form of infusions, under the supervision of a healthcare provider.
Here are a few examples of organizations that operate ketamine clinics in the U.S.:
-
Field Trip Health: Field Trip operates ketamine clinics in several cities across the U.S., including New York, Los Angeles, Chicago, and Atlanta. They provide ketamine-assisted therapy for conditions like depression and anxiety.
-
Mindbloom: a telemedicine platform that provides at-home ketamine treatment. They partner with licensed healthcare providers to offer ketamine therapy for conditions like depression and anxiety.
-
Ketamine Clinics of Los Angeles: This is a clinic that specializes in providing ketamine infusion therapy for conditions like depression, anxiety, PTSD, and chronic pain.
-
Polaris Insight Center: Based in San Francisco, Polaris offers ketamine-assisted psychotherapy for conditions like depression, anxiety, and PTSD.
It's important to note that while ketamine therapy can be effective for some patients, it's not suitable for everyone and can have serious side effects. Always consult with a healthcare provider before considering ketamine therapy.
In terms of other psychedelic substances, the FDA has granted "breakthrough therapy" designation to psilocybin therapy for treatment-resistant depression and to MDMA-assisted psychotherapy for PTSD, recognizing their potential as a significant improvement over existing treatments. This means that clinical trials are being conducted and, if they prove successful, these treatments could potentially become available in the future. However, as of now, they are not widely available outside of clinical trials.